Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,074 across all filing types
Latest filing 2025-10-09 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Alpha Group International plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. This specific form is used for 'Public Opening Position Disclosure/Dealing Disclosure'. Since it does not fit into the specific categories of M&A activity (which would be the company's own announcement) or other specific financial reports, it falls under the 'Regulatory Filings' (RNS) category as a standard regulatory disclosure.
2025-10-09 English
Form 8.3 - Dowlais Group Plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of Dowlais Group PLC. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Regulatory Filings' category as it does not fit into the specific categories for director dealings or major shareholding notifications (which are typically for the company's own shares or significant threshold changes by major investors).
2025-10-09 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Mural Oncology PLC). This type of filing is a standard regulatory disclosure regarding major shareholdings and derivative positions during an M&A event. Since it does not fit into the specific categories of M&A activity (which usually refers to the company's own announcements) or director dealings, and is a formal regulatory requirement, it is classified as a Regulatory Filing (RNS).
2025-10-09 English
Form 8.3 - American Axle & Manufacturing Holdings
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealing disclosures of a person with interests in relevant securities (Citadel Group) regarding an offeror/offeree (American Axle & Manufacturing Holdings Inc). This type of document is specifically used to report significant shareholdings and dealings during an M&A process, which falls under the 'Major Shareholding Notification' category.
2025-10-09 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act for persons with interests in relevant securities representing 1% or more of an offeror or offeree. This is a specific type of major shareholding and dealing disclosure related to takeover activity. While it involves shareholdings, it is distinct from a standard 'Major Shareholding Notification' (MRQ) because it is specifically tied to the regulatory framework of a takeover panel and includes detailed disclosure of derivatives and dealings. Given the specific regulatory nature and the lack of a more precise category for 'Takeover Panel Disclosures', it falls under the 'Regulatory Filings' (RNS) category as a fallback for specific regulatory announcements.
2025-10-08 English
Form 8.3 - Dowlais Group Plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in securities. Since this is a specific regulatory disclosure form related to takeover activity and does not fit into the other categories like M&A (which usually refers to the company's own announcements) or Director's Dealing, it is classified as a Regulatory Filing (RNS).
2025-10-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.